LAS VEGAS, Feb. 21, 2024 – Antigenne, a leader in pet reagent testing, drew a lot of attention from veterinarians and pet health professionals around the globe with its six years of expertise and excellence at the four-day World Veterinary Congress Annual Conference 2024 (WVC). The conference was held from 18th to 21st February.

The conference was held in Las Vegas from 18th to 21st February, bringing together veterinary experts, scholars, business representatives and pet lovers from all over the world to discuss the latest research results and development trends in the field of pet health, and Antigenne, as one of the exhibitors, demonstrated its professional strength and innovative achievements in the field of pet reagent testing.

Since its establishment, Antigenne has been committed to providing high-quality reagent testing products and services for pet health. With six years of experience and technological innovation, the company has become a leader in the industry, providing reliable testing solutions to pet owners and veterinarians worldwide.

Exhibition Introduction

At the exhibition, Antigenne showcased its latest pet reagent testing technologies and products, including rapid testing reagents for a variety of pet diseases, livestock, and avian animals, efficient and accurate diagnostic equipment, and user-friendly operating platforms. Such as Canine Distemper Virus Antigen Rapid Test, Toxoplasma Antibody Rapid Test, Brucella Antibody Rapid Test, Canine Infectious Hepatitis/Parvovirus/ Distemper Virus/Leptospira/Toxoplasma IgG Antibody Combo Test, and CANINE T&S IgE TEST KIT(T+80S). These innovations provide veterinarians and pet owners with more convenient and accurate diagnostic tools to help detect and treat pet diseases in a timely manner and improve pet health.

Antigenne’s booth attracted a large number of attendees, and many veterinarians and pet health experts came to discuss the development direction and application prospect of pet reagent testing technology, Antigenne’s professional team warmly received every visitor, patiently answered their questions, and shared their industry experience and insights.

Through this exhibition, Antigenne not only demonstrated its professional strength in the field of pet reagent testing but also further consolidated its relationship with global partners and expanded its market influence. Looking ahead, Antigenne will continue to dedicate itself to technological innovation and service quality improvement, contributing more to the global pet health cause.

As one of the exhibitors at the 2024 WVC Annual Conference, Antigenne brings new insights and possibilities to the global pet health field with its six years of experience in pet reagent testing. Its unique testing technology and user-friendly products have been widely praised, providing pet owners and veterinarians with a more convenient and accurate means of diagnosis for pet health.

At the exhibition, Antigenne’s team also actively participated in several forums and seminars, sharing its latest research results and experience in the field of pet reagent testing with global peers. These in-depth exchanges and discussions not only enhance the connection between Antigenne and its global partners but also promote the technological progress and development of the entire pet health field.

In addition, Antigenne used the opportunity to announce its strategic partnership plans with several leading global pet health companies. These plans will further strengthen Antigenne’s position in the global pet reagent testing market and drive further development and adoption of its technology.

Overall, Antigenne’s presence at the WVC Annual Congress 2024 was certainly a successful showcase. Its six years of experience in pet reagent testing, its innovative products and technologies, and its extensive global network of collaborations have earned Antigenne widespread recognition in the industry and among consumers.

Looking ahead, Antigenne will continue to uphold its mission and dedicate itself to contributing more to the cause of global pet health. Through continuous technological innovation and service quality improvement, Antigenne will endeavor to provide pet owners and veterinarians with more efficient and accurate reagent testing products and services to safeguard the health and quality of life of pets.

End of the exhibition

The trip to Las Vegas has undoubtedly injected new vigor into Antigenne’s global expansion and development. With its in-depth research and continuous innovation in the field of pet reagent testing, we have every reason to believe that Antigenne will play an even more important role in the future of pet health, providing better solutions and services to pet owners and veterinarians around the world.

Itgen, your pet health manager, always escorts your pet’s healthy life. Rapid detection results within 10 minutes, high sensitivity, simple operation, and more safe for small dogs and cats. If you need FPV, FIPV, FCoV, FeLV, FIV or CDV, CPV, CCV, CIV, CAV, EHR, ANA, CHW, BG rapid test kits, etc., you can contact us by email or phone.

Together, we can make a difference. Contact Antigenne now and let’s unlock the future of animal health.